Literature DB >> 27440165

Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Emmanuel Androulakis1, Nikolaos Papageorgiou2, Eirini Lioudaki3, Evaggelos Chatzistamatiou4, Effimia Zacharia4, Ioannis Kallikazaros4, Dimitris Tousoulis4.   

Abstract

The authors investigated the relationship of white-coat hypertension (WCH) with subclinical organ damage and potential relevant mechanisms. A total of 386 untreated patients were enrolled and divided into 204 patients with WCH and 183 with normotension. Flow-mediated dilation (FMD), pulse wave velocity (PWV), intima-media thickness, left ventricular mass index (LVMI), and cystatin C levels were measured. All tests were two-sided, and a P value <.05 was considered statistically significant. The WCH group exhibited higher LVMI and PWV values, decreased E/A ratio and FMD values, and increased prevalence for left ventricular hypertrophy compared with controls (P<.001 for all). Cystatin C was significantly higher in the WCH group compared with controls (P=.035) and was positively associated with LVMI (P<.05 for both). The presence of WCH is associated with more pronounced subclinical organ damage compared with normotension. Cystatin C may play a significant role and therefore warrants further investigation. ©2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27440165      PMCID: PMC8031092          DOI: 10.1111/jch.12882

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  45 in total

1.  Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study.

Authors:  Atsuhiro Kanno; Hirohito Metoki; Masahiro Kikuya; Hiroyuki Terawaki; Azusa Hara; Takanao Hashimoto; Kei Asayama; Ryusuke Inoue; Yoh Shishido; Masaaki Nakayama; Kazuhito Totsune; Takayoshi Ohkubo; Yutaka Imai
Journal:  Hypertens Res       Date:  2010-08-12       Impact factor: 3.872

2.  Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.

Authors:  Giuseppe Mancia; Rita Facchetti; Michele Bombelli; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

Review 3.  A new approach for evaluating renal function and its practical application.

Authors:  Akihiro Tanaka; Katsuya Suemaru; Hiroaki Araki
Journal:  J Pharmacol Sci       Date:  2007-09-08       Impact factor: 3.337

Review 4.  Inflammatory markers in essential hypertension: potential clinical implications.

Authors:  Elli Stefanadi; Dimitris Tousoulis; Emmanuel S Androulakis; Nikolaos Papageorgiou; Marietta Charakida; Gerasimos Siasos; Costas Tsioufis; Christodoulos Stefanadis
Journal:  Curr Vasc Pharmacol       Date:  2010-07       Impact factor: 2.719

Review 5.  Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis.

Authors:  Cesare Cuspidi; Carla Sala; Marijana Tadic; Marta Rescaldani; Guido Grassi; Giuseppe Mancia
Journal:  Blood Press Monit       Date:  2015-04       Impact factor: 1.444

6.  Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors:  Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

7.  Target organ damage in "white coat hypertension" and "masked hypertension".

Authors:  Vasilios Kotsis; Stella Stabouli; Savvas Toumanidis; Christos Papamichael; John Lekakis; George Germanidis; Apostolos Hatzitolios; Zoe Rizos; Michael Sion; Nikos Zakopoulos
Journal:  Am J Hypertens       Date:  2008-02-21       Impact factor: 2.689

8.  Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.

Authors:  Dimitris Tousoulis; Emmanuel Androulakis; Nikolaos Papageorgiou; Antigoni Miliou; Evaggelos Chatzistamatiou; Evaggelos Oikonomou; George Moustakas; Ioannis Kallikazaros; Christodoulos Stefanadis
Journal:  Am J Hypertens       Date:  2013-03-11       Impact factor: 2.689

9.  White coat hypertension is more risky than prehypertension: important role of arterial wave reflections.

Authors:  Shih-Hsien Sung; Hao-Min Cheng; Kang-Ling Wang; Wen-Chung Yu; Shao-Yuan Chuang; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

10.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

View more
  8 in total

1.  Cystatin C as a biomarker of chronic kidney disease: latest developments.

Authors:  Stefanie W Benoit; Eileen A Ciccia; Prasad Devarajan
Journal:  Expert Rev Mol Diagn       Date:  2020-05-25       Impact factor: 5.225

2.  Endothelial function in children with white-coat hypertension.

Authors:  Alexander Jurko; Tomas Jurko; Milan Minarik; Michal Mestanik; Andrea Mestanikova; Vladimir Micieta; Zuzana Visnovcova; Ingrid Tonhajzerova
Journal:  Heart Vessels       Date:  2018-01-29       Impact factor: 2.037

3.  Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia Network.

Authors:  Kazuomi Kario; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Yook-Chin Chia; Romeo Divinagracia; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Yuqing Zhang; Sungha Park; Huynh Van Minh; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09       Impact factor: 3.738

Review 4.  White coat syndrome and its variations: differences and clinical impact.

Authors:  Mariana R Pioli; Alessandra Mv Ritter; Ana Paula de Faria; Rodrigo Modolo
Journal:  Integr Blood Press Control       Date:  2018-11-08

5.  Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy.

Authors:  Yi Shen; Xiaoyi Zhang; Chenguang Li; Xiang Wang; Yong Ye; Jie Yuan; Hui Gong; Yunzeng Zou; Junbo Ge
Journal:  Ann Transl Med       Date:  2020-11

6.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

Review 7.  Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis.

Authors:  Christina Antza; Polychronis Vazakidis; Ioannis Doundoulakis; Emmanouil Bouras; Anna-Bettina Haidich; Stella Stabouli; Vasilios Kotsis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-01       Impact factor: 3.738

Review 8.  Effect of white-coat hypertension on arterial stiffness: A meta-analysis.

Authors:  Peng Cai; Yan Peng; Yan Wang; Xukai Wang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.